ARCUTIS BIOTHERAPEUTICS, INC.: current liabilities
Current liabilities for ARCUTIS BIOTHERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ARCUTIS BIOTHERAPEUTICS, INC. financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 129,838,000 | USD | 2026-02-25 | 10-K · 0001787306-26-000018 |
| At date | 2024-12-31 | 81,013,000 | USD | 2026-02-25 | 10-K · 0001787306-26-000018 |
| At date | 2023-12-31 | 46,668,000 | USD | 2025-02-25 | 10-K · 0001787306-25-000029 |
| At date | 2022-12-31 | 37,807,000 | USD | 2024-02-27 | 10-K · 0001787306-24-000031 |
| At date | 2021-12-31 | 33,326,000 | USD | 2023-02-28 | 10-K · 0001787306-23-000023 |
| At date | 2020-12-31 | 22,602,000 | USD | 2022-02-22 | 10-K · 0001787306-22-000009 |
| At date | 2019-12-31 | 5,237,000 | USD | 2021-02-16 | 10-K · 0001628280-21-002272 |
Related financial histories
- ARCUTIS BIOTHERAPEUTICS, INC.: total assets
- ARCUTIS BIOTHERAPEUTICS, INC.: total liabilities
- ARCUTIS BIOTHERAPEUTICS, INC.: stockholders equity
- ARCUTIS BIOTHERAPEUTICS, INC.: cash and cash equivalents
- ARCUTIS BIOTHERAPEUTICS, INC.: net income or loss
- ARCUTIS BIOTHERAPEUTICS, INC.: operating cash flow
- ARCUTIS BIOTHERAPEUTICS, INC.: capital expenditure payments
- ARCUTIS BIOTHERAPEUTICS, INC.: revenue
- ARCUTIS BIOTHERAPEUTICS, INC.: financing cash flow
- ARCUTIS BIOTHERAPEUTICS, INC.: investing cash flow
- ARCUTIS BIOTHERAPEUTICS, INC.: retained earnings or deficit
- ARCUTIS BIOTHERAPEUTICS, INC.: basic weighted-average shares
- ARCUTIS BIOTHERAPEUTICS, INC.: diluted weighted-average shares
- ARCUTIS BIOTHERAPEUTICS, INC.: basic earnings per share
- ARCUTIS BIOTHERAPEUTICS, INC.: diluted earnings per share
- ARCUTIS BIOTHERAPEUTICS, INC.: income tax expense or benefit
- ARCUTIS BIOTHERAPEUTICS, INC.: net property, plant and equipment
- ARCUTIS BIOTHERAPEUTICS, INC.: share-based compensation expense
- ARCUTIS BIOTHERAPEUTICS, INC.: operating income or loss
- ARCUTIS BIOTHERAPEUTICS, INC.: current assets
- ARCUTIS BIOTHERAPEUTICS, INC.: interest expense
- ARCUTIS BIOTHERAPEUTICS, INC.: current accounts payable
- ARCUTIS BIOTHERAPEUTICS, INC.: net finite-lived intangible assets
- ARCUTIS BIOTHERAPEUTICS, INC.: net current accounts receivable
- ARCUTIS BIOTHERAPEUTICS, INC.: operating expenses
- ARCUTIS BIOTHERAPEUTICS, INC.: net inventory
- ARCUTIS BIOTHERAPEUTICS, INC.: selling, general and administrative expense
- ARCUTIS BIOTHERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- ARCUTIS BIOTHERAPEUTICS, INC. / CIK 0001787306
- Captured
- 2026-09-21T17:31:32.837Z
- SEC response SHA-256
e10fdeb472e3eb1460936c194c8109f22df3f8bd8bc987f00f57e5a3a517070f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001787306.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))